Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02549638 · ClinicalTrials.gov registry record
Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 22
- Enrollment target
NCT02549638: Clinical Trial study, sponsored by Mayo Clinic.
NCT02549638 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02549638 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 22 participants
- Enrollment target
Study Summary
The study will utilize both retrospective and prospective data collection from patients that already had a bronchoscopy and lung resection or will have a bronchoscopy and lung resection for squamous cell carcinoma. The investigators plan to prospectively collect 5 bronchoscopic biopsies, 10ml blood and one tumor and adjacent normal samples from 200 qualified patients who meet the study criteria.
Interventions
- GENETIC DNA Extraction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2015-04-08 |
| Est. Completion | 2020-04-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02549638
The ClinicalTrials.gov registry entry for NCT02549638 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DNA Extraction is the first listed.
NCT02549638 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02549638 about?
NCT02549638 is a clinical study titled "Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma". The study will utilize both retrospective and prospective data collection from patients that already had a bronchoscopy and lung resection or will have a bronchoscopy and lung resection for squamous cell carcinoma. The investigators plan to prospectively collect 5 bronchoscopic biopsies, 10ml blood ...
What is the current status of trial NCT02549638?
This trial is currently terminated. The enrollment target is 22 participants. The study started on 2015-04-08. Estimated completion is 2020-04-23.
What interventions are being tested in trial NCT02549638?
The interventions under investigation include: DNA Extraction (GENETIC).
Who is sponsoring clinical trial NCT02549638?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.